Pricing

Benitec Biopharma Ltd ADR (BNTC)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jerel A. Banks
Employees:
20
3940 TRUST WAY, HAYWARD, CA, 94545
(510) 780-0819
    Formally known as:
  • BENITEC BIOP DRC
  • Benitec Biopharma Inc.
  • BENITEC BIOPHARMA LT (AUS)
  • BENITEC BIOPHARMA LT (AUS)
  • BENITEC BIOPHARMA LT (AUS)
  • BENITEC BIOPHARMA LT (AUSTRALIA)
Stock Split History
DateRatio
2015-06-16 1:4
2019-11-18 1:10
2020-04-15 2:3
2023-07-26 1:17
Benitec Biopharma focuses on the development of novel genetic medicines. The company is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. BB-103 for the treatment of chronic hepatitis B virus infection.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available